Patents by Inventor Yasutaka Nagisa

Yasutaka Nagisa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy
    Publication number: 20060189669
    Abstract: To provide a pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy or preproliferative retinopathy, comprising a compound having angiotensin II antagonistic activity, or a salt thereof.
    Type: Application
    Filed: April 19, 2006
    Publication date: August 24, 2006
    Inventors: Shizue Nakagawa, Yasutaka Nagisa, Hitoshi Ikeda
  • Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy
    Patent number: 7064141
    Abstract: To provide a pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy or preproliferative retinopathy, comprising a compound having angiotensin II antagonistic activity, or a salt thereof.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: June 20, 2006
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shizue Nakagawa, Yasutaka Nagisa, Hitoshi Ikeda
  • Screening method
    Publication number: 20050142065
    Abstract: The present invention provides a method of screening for an agent for the treatment of human diabetes mellitus, which comprises administering a test compound to a diabetes mellitus model non-human mammal, and selecting a compound that causes a decrease of not less than 0.5% in a glycated hemoglobin value after administration.
    Type: Application
    Filed: April 24, 2003
    Publication date: June 30, 2005
    Inventors: Koki Kato, Yasutaka Nagisa, Hiroyuki Odaka
  • Treatment of cerebral infarction using cyclic hexapeptides
    Patent number: 6251861
    Abstract: A pharmaceutical composition comprising a compound having anti-endothelin activity is useful for the prophylaxis or treatment of cerebral infarction.
    Type: Grant
    Filed: June 24, 1997
    Date of Patent: June 26, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tetsuji Imamoto, Yasutaka Nagisa